The equivalent bronchodilator effects of salbutamol formulated in chlorofluorocarbon and hydrofluoroalkane-134a metered dose inhalers on the histamine-induced pulmonary response in dogs

Pharmaceutical Research

Volumn 14, Issue 2, 1997, Pages 208-212

  Nogami Itoh, Mari ^a   Yakuo, Ikuhisa ^a   Hammerbeck, David M ^b   Miller, Richard L ^b   Takeyama, Kunihiko ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^b 3M COMPANY   (United States)

Author keywords

Bioequivalent; Hydrofluoroalkane 134a (HFA 134a); Konzett Rossler; Salbutamol

Indexed keywords

CHLOROFLUOROCARBON; HISTAMINE; NORFLURANE; SALBUTAMOL; SALBUTAMOL SULFATE;

ANIMAL EXPERIMENT; ARTICLE; BIOEQUIVALENCE; BRONCHOSPASM; CONTROLLED STUDY; DOG; INHALATIONAL DRUG ADMINISTRATION; LUNG RESISTANCE; MALE; METERED DOSE INHALER; NONHUMAN; PRIORITY JOURNAL;

ALBUTEROL; ANIMALS; BLOOD PRESSURE; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CHLOROFLUOROCARBONS; DOGS; HEART RATE; HISTAMINE; HYDROCARBONS, FLUORINATED; MALE; NEBULIZERS AND VAPORIZERS; THERAPEUTIC EQUIVALENCY;

EID: 0030962471     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012056928780     Document Type: Article

References (8)

1. Montreal Protocol. Sept. 16, 1987, 26 ILM 1541 (1987).
2. E. R. Bleecker, N. M. Klinger, B. P. Ekholm, and D. G. Tinkelman. Am. J. Respir. Crit. Care Med. 151:A58 (1995).
3. M. Jenkins. J. Aerosol Med. 8:541-547 (1995).
4. R. Ruffin, C. Mitchell, P. Thompson, D. Harle, A. Cline, and B. P. Ekholm. Am. J. Respir. Crit. Care Med. 151:A58 (1995).
5. H. Konzett, and R. Rossler. Arch. Exp. Path. Pharmak. 195:71-74 (1940).
6. V. A. Cullum, J. B. Farmer, D. Jack and G. P. Levy. Br. J. Pharmacol. 35:141-151 (1969).
7. Y. Yabuuchi, S. Yamashita, and S. Tei. J. Pharmacol. Exp. Ther. 202:326-336 (1977).
8. E. E. Daniel, A. P. Abela, L. J. Janssen, and P. M. O'Byrne. Can. J. Physiol. Pharmacol. 70:624-634 (1992).